Swartz, James A.
Zhao, Peipei
Jacobucci, Ross
Watson, Dennis P.
Mackesy-Amiti, Mary Ellen
Franceschini, Dana
Jimenez, A. David
Article History
Received: 4 January 2024
Accepted: 20 June 2024
First Online: 25 June 2024
Declarations
:
: The two component studies on which this secondary analysis was based were reviewed and approved by the University of Illinois Chicago (UIC), University of Notre Dame, and Chestnut Health Systems IRBs. As the second study was a randomized controlled trial (RCT), the UIC and Chestnut Health Systems IRBs also reviewed and approved the RCT study protocol (NCT04575324).
: Not applicable.
: The authors declare no competing interests.